Unlocking Insights
in Cardiology
LynxCare's comprehensive data assets* offer fresh insights into Heart Failure and Atrial Fibrillation (AFib), including comorbidity factors and treatment patterns.
Our granular and quality controlled real-world datasets can unlock invaluable insights into the treatment and prognosis of various cardiac diseases, empowering clinicians to make informed decisions. Through our federated real-world dataset, we can equally help life sciences close evidence gaps throughout the product lifecycle, from development to launch and growth.
Click below and discover our Heart Failure and Atrial Fibrillation (AFib) dataset insights.
SOON AVAILABLE!
Advancing Research
Peer-Reviewed Publications
Explore our groundbreaking research in heart failure through our peer-reviewed publications.
Presented Conference Abstracts
Gain valuable insights into heart failure as our experts share their knowledge at scientific conferences.
Reach Out
Building Trust
Quality Control and Data Freshness
Quality Control
We adhere to strict data quality standards to ensure the accuracy and reliability of our data. Our team of experts verifies and validates data from intake, data processing up till analytics, ensuring consistency and completeness throughout the patient pathway. Each statistic needs to be validated by the individual hospital before delivery.
Data Freshness
Our data is updated regularly to ensure we provide insights based on the latest and most accurate information. Leveraging our HL7-based gateway, our datasets remain fresh with a max of 6-months delay.
OMOP CDM Data Warehouse
Our data is stored in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), enabling easy access and integration with other healthcare or research IT solutions. With our well-structured and standardized data storage, our clients can start analyzing the data immediately and efficiently.
The Future of Cardiac Treatments
How LynxCare Can Help
Personalized Medicine
By providing insights into individual pathways of heart failure patients, our data asset enables clinicians to tailor treatments to specific patient needs, opening up the possibility of personalized medicine (ATTR-CM, Cardiorenal syndrome, SGLT-2 eligibility,...)
Improved Outcomes
By providing insights into the clinical pathway of heart failure patients, our data asset aims to ultimately improve patient outcomes by providing valuable insights for clinicians and researchers (e.g. impact on mortality when admitted via geriatrics).
Continued Innovation
With our comprehensive dataset and world-class expertise, we aim to continue to drive innovation in heart failure treatment and management, ensuring that the latest insights and solutions are available to healthcare providers and researchers.
* LynxCare datasets concern datasets within the LynxCare's European hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.